CAR T-cell treatment of high-risk multiple myeloma: will there be a cure?

被引：1
|
作者：
Gahrton, Gosta [1 ]
机构：
[1] Karolinska Inst, Dept Med, Stockholm, Sweden
来源：
HAEMATOLOGICA | 2023年 / 108卷 / 10期
关键词：
BONE-MARROW-TRANSPLANTATION; THERAPY;
D O I：
10.3324/haematol.2023.282896
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2568 / 2569
页数：2
相关论文
共 50 条
  • [21] Chimeric antigen receptor (CAR) T-cell therapy for multiple myeloma
    Choi, Taewoong
    Kang, Yubin
    PHARMACOLOGY & THERAPEUTICS, 2022, 232
  • [22] CAR T-cell therapy in multiple myeloma: more room for improvement
    Phaik Ju Teoh
    Wee Joo Chng
    Blood Cancer Journal, 11
  • [23] Frontline Treatment for High-Risk Multiple Myeloma: Personalized?
    Usmani, Saad
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S89 - S89
  • [24] Bispecific T-cell engagers for treatment of multiple myeloma
    Ravi, Gayathri
    Costa, Luciano J.
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 : S13 - S21
  • [25] Nivolumab to restore T-cell fitness in CAR-T refractory multiple myeloma
    Waldschmidt, Johannes M.
    Sotudeh, Noori
    Arora, Sankalp
    Vijaykumar, Tushara
    Anand, Praveen
    Stuart, Hannah
    Frede, Julia
    Campbell, Tim
    Kaiser, Shari M.
    Zheng, Xirong
    Munshi, Nikhil C.
    Anderson, Kenneth C.
    Einsele, Hermann
    Yee, Andrew J.
    Knoechel, Birgit
    Lohr, Jens G.
    Raje, Noopur S.
    BLOOD ADVANCES, 2025, 9 (05) : 1132 - 1136
  • [26] T-cell phenotypes associated with effective CAR T-cell therapy in postinduction vs relapsed multiple myeloma
    Garfall, Alfred L.
    Dancy, Ehren K.
    Cohen, Adam D.
    Hwang, Wei-Ting
    Fraietta, Joseph A.
    Davis, Megan M.
    Levine, Bruce L.
    Siegel, Don L.
    Stadtmauer, Edward A.
    Vogl, Dan T.
    Waxman, Adam
    Rapoport, Aaron P.
    Milone, Michael C.
    June, Carl H.
    Melenhorst, J. Joseph
    BLOOD ADVANCES, 2019, 3 (19) : 2812 - 2815
  • [27] Real-world efficacy of CAR T-cell therapies: a HealthTree cure hub's study of multiple myeloma patients
    Hydren, Jay
    Martinez, Jorge Arturo Hurtado
    Sweeney, Nathan
    Perez, Patricia Alejandra Flores
    Espinoza, Andrea Isabel Robles
    Ahlstrom, Jennifer
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S42 - S42
  • [28] Determinants of Response and Mechanisms of Resistance of CAR T-cell Therapy in Multiple Myeloma
    van de Donk, Niels W. C. J.
    Themeli, Maria
    Usmani, Saad Z.
    BLOOD CANCER DISCOVERY, 2021, 2 (04): : 302 - 318
  • [29] CAR T-Cell Therapy for Patients with Multiple Myeloma: Current Evidence and Challenges
    Rendo, Matthew J.
    Joseph, Jacinth J.
    Phan, Liem Minh
    DeStefano, Christin B.
    BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY, 2022, 12 : 119 - 136
  • [30] CD4+CAR T-cell exhaustion associated with early relapse of multiple myeloma after BCMA CAR T-cell therapy
    Ledergor, Guy
    Fan, Zenghua
    Wu, Kai
    Mccarthy, Elizabeth
    Hyrenius-Wittsten, Axel
    Starzinski, Alec
    Chang, Hewitt
    Bridge, Mark
    Kwek, Serena
    Cheung, Alexander
    Bylsma, Sophia
    Hansen, Erik
    Wolf, Jeffrey
    Wong, Sandy
    Shah, Nina
    Roybal, Kole T.
    Martin, Thomas
    Ye, Chun J.
    Fong, Lawrence
    BLOOD ADVANCES, 2024, 8 (13) : 3562 - 3575
12345